 Analysts expect NeuBase Therapeutics NASDAQ:NBSE to post earnings per share EPS of 0.24 for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for NeuBase Therapeutics earnings, with estimates ranging from 0.24 to 0.23. NeuBase Therapeutics reported earnings per share of 0.40 during the same quarter last year, which would indicate ... 